LoginRegister

    Lupin gets USFDA nod for infection treating drug

    Written by Ruby Khatun Khatun   |  
    Lupin gets USFDA nod for infection treating drug

    New Delhi: Drug major Lupin said it has received approval from the US health regulator for its doxycycline hyclate tablets used for the treatment of various infections.


    The company has received USFDA final approval for its doxycycline hyclate tablets in the strengths of 75 mg and 150 mg, Lupin said in a BSE filing.


    The product is a generic version of Aqua Pharmaceuticals LLC's acticlate tablets.


    As per IMS MAT June 2017 data, doxycycline hyclate tablets had annual sales of approximately USD 263 million in the US.


    The drug is used for the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne, the company said.

    acticlate tabletsapprovalAqua PharmaceuticalsDoxycycline hyclate tabletsgenericinfection treating druginfectionsLupinUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X